JESSICA DOWGIERT: Open Payments
NPI 1558072025 · LOUISVILLE, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,270 in 50 payments from 18 companies in 2025. Trend: 2023 $508 · 2024 $1,647 · 2025 $1,270
Food & beverage: $1,270
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 8 | $148 |
| Novo Nordisk Inc | 4 | $131 |
| Alnylam Pharmaceuticals Inc. | 4 | $129 |
| Edwards Lifesciences Corporation | 1 | $126 |
| Amgen Inc. | 5 | $125 |
| Medtronic, Inc. | 1 | $108 |
| SCPHARMACEUTICALS INC. | 5 | $82 |
| Merck Sharp & Dohme LLC | 4 | $82 |
| HEARTFLOW, INC. | 4 | $69 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $64 |
Products named: Wegovy, AMVUTTRA, Repatha, LINQ II, CAMZYOS, FUROSCIX, FFRct, VERQUVO.
Industry payments across CO — which companies pay providers there.
